TTK and cancer: We argue that the nature and extent of the stabilising interactions between Mps1 and genistein represents a new molecular scaffold to develop new semi-synthetic compounds to tackle aggressive cancer types associated with chromosome segregation defects and/or where Mps1 kinase is amplified or constitutively active.